Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Bryan L. Cockroft
You’ve Got A Friend In Me: House Bill 236 Requires Providers to Accommodate Patient’s Chosen Advocates | JD Supra
Stemming from concerns raised during the COVID pandemic, the Ohio General Assembly recently passed House Bill 236, dubbed the “Never Alone Act,” (“Act”) which became effective March 20, 2025. The law requires a wide range of “congregate care facilities” to allow patients/residents to designate an “advocate” and prohibits such facilities from denying the patient or resident access to the advocate under certain specified circumstances.
DEA Expands Telemedicine Flexibilities Through Three New Rules | JD Supra
The landscape of telemedicine in the United States is undergoing a profound transformation. On January 16, 2025, the Drug Enforcement Administration (DEA) unveiled a series of regulatory changes designed to expand and solidify telemedicine practices.[i] These changes aim to increase access to care, ensure continuity of treatment and provide permanent frameworks for prescribing controlled substances remotely.
Pennsylvania Court Rules Non-Compete Ban Can Stand | JD Supra
In another update to the Federal Trade Commission’s (the “FTC”) Non-Compete Ban (the “Rule”), a federal judge in Pennsylvania ruled against ATS Tree Services, LLC v. Federal Trade Commission, et al.[1] denying ATS’ motion for a preliminary injunction.
Rescheduling Marijuana and its Impact on Healthcare and the Economy | JD Supra
The United States is on the verge of one of the biggest, if not the biggest, transformations to marijuana policy in the last 50 years. According to an Associated Press report, the Drug Enforcement Administration (DEA) is expected to reschedule marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act (CSA).
Questions Abound in the Healthcare Industry after Federal Trade Commission Bans Non-Competes | JD Supra
On April 23, 2024, the Federal Trade Commission (“FTC”) voted to issue a final rule banning non-compete provisions in most industries in the United States (“Final Rule”). Dinsmore attorneys were quick to publish the details and impact of the Final Rule, which is available here.
Feeling Lucky? Lottery to Decide Cannabis Business Licensees in Kentucky | JD Supra
In the latest update to Kentucky’s Medical Cannabis Program (the “Program”), Governor Andy Beshear signed House Bill 829 which moved up the timeline to apply for cannabis business licenses by six months. Additionally, two emergency regulations were issued by the Program that explain how to apply for a cannabis business license.
Kentucky Senator Introduces Legislation to Combat Discrimination in the 340B Drug Program | JD Supra
State efforts to address the 340B Drug Program[1] continue to ramp up in 2024. Early this January, Kentucky Senator Stephen Meredith introduced Senate Bill 27 ("SB-27"), which intends to address a number of purchasing restrictions drug manufacturers unilaterally imposed on health care providers participating in the 340B Program.
[Webinar] Medical Marijuana Laws in Kentucky - What You Need to Know - February 21st, 12:00 pm - 1:00 pm ET | JD Supra
The vast majority of States and the District of Columbia have now legalized the use of medical marijuana, with Kentucky set to join this list in 2025. The fast pace and varied approaches seen in this emerging field have created a multitude of legal and practical considerations that can impact individuals and entities alike.
$9 Billion+ to be Repaid to 340B Hospitals- Is your Hospital Eligible? | JD Supra
In June of 2022, the Supreme Court of the United States unanimously held in American Hospital Association v.
DEA Further Extends Telemedicine Prescribing Flexibilities | JD Supra
October 13, 2023 To embed, copy and paste the code into your website or blog: The Drug Enforcement Administration (DEA) is once again extending telemedicine prescribing flexibilities for controlled substances.
CISA FBI AvosLocker Ransomware Advisory
The Cybersecurity & Infrastructure Security Agency (CISA) and the Federal Bureau of Investigation (FBI) released a Joint Cybersecurity Advisory on October 11, 2023, urging companies (particularly those in the critical infrastructure sector) to take steps to mitigate cyber threats for AvosLocker Ransomware.
Fifth Circuit Court Keeps Abortion Medication Legal, But With Restrictions | JD Supra
The 5th Circuit Court of Appeals in New Orleans upheld parts of a Texas District Court ruling by restricting the use of Mifepristone, while allowing Mifepristone to remain on the market.[1] This is the latest ruling in an ongoing legal battle that has left the future of abortion medications in a state of flux. Dinsmore previously discussed the original April 2023 ruling that led to the most recent development.
CMS Publishes Proposed Rules for OPPS, ASC and PFS for Calendar Year 2024 | JD Supra
The Centers for Medicare & Medicaid Services (“CMS”) has announced its proposed rules for the Hospital Outpatient Prospective Payment (“OPPS”) and Ambulatory Surgical Center (“ASC”) Payment Systems, as well as its calendar year (CY) 2024 proposed Physician Fee Schedule (“PFS”), (collectively the “Proposed Rules”).
FTC and DOJ Take Key Actions with Antitrust Guidance Affecting Healthcare | JD Supra
This year, the Federal Trade Commission (the “FTC”) and the Department of Justice (the “DOJ”) have been modifying antitrust guidance related to healthcare, and recently enacted three notable changes. First, the FTC and DOJ jointly issued updated Draft Merger Guidelines (the “Draft Guidelines”) to address the way the agencies evaluate a merger to determine its effect on competition.
Contradictory Court Opinions Leave the Approval of Abortion Medication in Question | JD Supra
On April 7, 2023, two federal judges in Texas and Washington State issued dueling opinions about the abortion medication Mifepristone, just hours apart. These two decisions come in the midst of growing tension about abortion laws in the United States after the Dobbs v. Jackson Women’s Health Organization decision released by the Supreme Court in 2022.[i] The Texas and Washington court opinions do not help reduce the confusion among healthcare providers and residents of the United States.
Medical Marijuana Will Soon be Legal in Kentucky | JD Supra
On March 31, 2023, Governor Andy Beshear signed Senate Bill 47 making medical marijuana use and sale legal in Kentucky, effective January 1, 2025. [i] Kentucky now joins at least 37 other states that have legalized medical marijuana. The newest piece of legislation comes on the heels of Governor Beshear signing two executive orders related to cannabis in November of 2022.
Contradictory Court Opinions Leave the Approval of Abortion Medication in Question
On April 7, 2023, two federal judges in Texas and Washington State issued dueling opinions about the abortion medication Mifepristone, just hours apart. These two decisions come in the midst of growing tension about abortion laws in the United States after the Dobbs v. Jackson Women’s Health Organization decision released by the Supreme Court in 2022.[i] The Texas and Washington court opinions do not help reduce the confusion among healthcare providers and residents of the United States.
D.C. District Court Rules HHS Will be in Charge of OPPS Repayments
On January 10, the United States District Court for the District of Columbia issued a long-awaited opinion which will allow the U.S. Department of Health and Human Services (HHS) to determine the means by which it will repay inappropriate cuts it levied against 340B participating hospitals’ Medicare reimbursement.[i] The District Court’s decision comes on the heels of the United States Supreme Court’s unanimous decision in American Hospital Association v. Becerra, 142 S.
Bryan L. Cockroft
Legal Disclaimer You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Bryan L.
Contact Bryan L., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack